Abstract

BackgroundLung cancer is the leading cause of cancer-related death. While cigarette smoking is the primary cause of this malignancy, risk differs across racial/ethnic groups. For the same number of cigarettes smoked, Native Hawaiians compared to whites are at greater risk and Japanese Americans are at lower risk of developing lung cancer. DNA methylation of specific CpG sites (e.g., in AHRR and F2RL3) is the most common blood epigenetic modification associated with smoking status. However, the influence of internal smoking dose, measured by urinary nicotine equivalents (NE), on DNA methylation in current smokers has not been investigated, nor has a study evaluated whether for the same smoking dose, circulating leukocyte DNA methylation patterns differ by race.MethodsWe conducted an epigenome-wide association study (EWAS) of NE in 612 smokers from three racial/ethnic groups: whites (n = 204), Native Hawaiians (n = 205), and Japanese Americans (n = 203). Genome-wide DNA methylation profiling of blood leukocyte DNA was measured using the Illumina 450K BeadChip array. Average β value, the ratio of signal from a methylated probe relative to the sum of the methylated and unmethylated probes at that CpG, was the dependent variables in linear regression models adjusting for age, sex, race (for pan-ethnic analysis), and estimated cell-type distribution.ResultsWe found that NE was significantly associated with six differentially methylated CpG sites (Bonferroni corrected p < 1.48 × 10−7): four in or near the FOXK2, PBX1, FNDC7, and FUBP3 genes and two in non-annotated genetic regions. Higher levels of NE were associated with increasing methylation beta-valuesin all six sites. For all six CpG sites, the association was only observed in Native Hawaiians, suggesting that the influence of smoking dose on DNA methylation patterns is heterogeneous across race/ethnicity (p interactions < 8.8 × 10−8). We found two additional CpG sites associated with NE in only Native Hawaiians.ConclusionsIn conclusion, internal smoking dose was associated with increased DNA methylation in circulating leukocytes at specific sites in Native Hawaiian smokers but not in white or Japanese American smokers.

Highlights

  • Lung cancer is the leading cause of cancer-related death

  • Lifetime smoking quantity was lowest in Native Hawaiians (42.4 pack-years), which is expected as Native Hawaiians on average were younger at time of urine collection, followed by Japanese Americans (44.7 pack-years) and whites (56.8 pack-years)

  • Among 35 never smokers (11 Japanese Americans, 12 Native Hawaiians, and 12 whites) who were included in only the epigenome-wide association studies (EWAS) of smoking status, the distribution of males and females were ~ 50% in each racial/ethnic group

Read more

Summary

Introduction

Lung cancer is the leading cause of cancer-related death. While cigarette smoking is the primary cause of this malignancy, risk differs across racial/ethnic groups. Park et al Clinical Epigenetics (2018) 10:110 their smoking intensity and nicotine metabolism rate, measured by CYP2A6 activity (the ratio of total trans3′-hydroxycotinine over total cotinine), which is intermediate between that of whites and Japanese Americans. To date, this higher risk in Native Hawaiians is not explained by other known lung cancer risk factors. No study has evaluated whether peripheral blood DNA methylation patterns differ by race/ethnicity for the same NE Characterization of these differences might be enlightening since racial/ethnic groups have been found to have variations in nicotine uptake per cigarette [5]. The differential impact of smoking dose on the epigenome may in part contribute to the ethnic variations in smoking-related lung cancer risk

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call